Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Textron Receives Upgrade to Buy Rating with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
TMUS stock news
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, Textron (NYSE:TXT) received a significant upgrade from B of A Securities analyst Ronald Epstein. Moving from a Neutral rating to a Buy, the price target was also increased from $85 to $105. This upgrade signifies a bullish perspective on Textron’s future performance and growth prospects.

TXT Stock Fluctuates on March 8, 2024: Pre-Market Trading Shows Positive Momentum

On March 8, 2024, TXT stock experienced some fluctuations in its performance. According to data from CNN Money, TXT is currently trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well in the long term.

However, on this particular day, the price of TXT shares decreased by $0.26 since the market last closed, representing a 0.29% drop. The stock closed at $90.32, but it has since risen by $1.72 in pre-market trading. This increase in pre-market trading suggests that there may be some positive momentum building for TXT stock.

TXT Stock Performance Analysis: Strong Financial Results Drive Investor Confidence

On March 8, 2024, investors were closely watching the stock performance of TXT, a company that has been making waves in the market with its strong financial performance. According to data from CNN Money, TXT reported total revenue of $13.68 billion over the past year, with $3.89 billion in revenue for the fourth quarter. This represents a 6.33% increase in total revenue since the previous year, and revenue held steady from the previous quarter.

In terms of net income, TXT reported $921 million in net income for the past year, with $199 million in net income for the fourth quarter. This represents a 6.97% increase in net income since the previous year, and net income held steady from the previous quarter.

Earnings per share (EPS) for TXT stood at $4.56 for the past year and $1.00 for the fourth quarter. This represents a 13.96% increase in EPS since the previous year, and EPS held steady from the previous quarter.

Overall, TXT’s financial performance has been strong, with consistent growth in total revenue, net income, and EPS. Investors may have been pleased with the company’s ability to maintain its financial performance despite economic uncertainties. The stock performance on March 8, 2024, may have reflected this positive sentiment, with the potential for an increase in share price as investors continue to monitor TXT’s performance in the market.

Tags: TXT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Ovid Therapeutics Q4 Earnings Report Key Points and Analysis

Finance_Assets

Analyst Upgrades PPL to Buy with 30 Price Target

Finances

Analyst Jason Helfstein Downgrades FIGS Rating from Outperform to Perform

Recommended

Coinbase Stock

Coinbase Expands Its Strategic Footprint Across Multiple Fronts

1 month ago
AnaptysBio Stock

AnaptysBio Shares Approach Critical Juncture as Key Events Loom

7 months ago
Origin Materials Stock

Can Origin Materials Stock Recover From Its Steep Decline?

4 months ago
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

Energiekontor Stock Gains Momentum from Policy Shifts

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Trending

TeamViewer Stock
Analysis

TeamViewer’s SDAX Debut Coincides With Share Price Weakness

by SiterGedge
March 25, 2026
0

TeamViewer's formal move to Germany's SDAX index represents more than a symbolic shift, occurring alongside a cautious...

Shell Stock

Shell Shares Face Analyst Downgrade Following Quarterly Results

March 25, 2026
Heidelberg Materials Stock

Heidelberg Materials Stock Gains on Strong Fundamentals

March 25, 2026
Glencore Stock

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • TeamViewer’s SDAX Debut Coincides With Share Price Weakness
  • Shell Shares Face Analyst Downgrade Following Quarterly Results
  • Heidelberg Materials Stock Gains on Strong Fundamentals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com